213 related articles for article (PubMed ID: 23925391)
1. Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling.
Staines KA; Zhu D; Farquharson C; MacRae VE
J Bone Miner Metab; 2014 May; 32(3):240-51. PubMed ID: 23925391
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix mineralization promotes E11/gp38 glycoprotein expression and drives osteocytic differentiation.
Prideaux M; Loveridge N; Pitsillides AA; Farquharson C
PLoS One; 2012; 7(5):e36786. PubMed ID: 22586496
[TBL] [Abstract][Full Text] [Related]
3. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization.
Lynch MP; Stein JL; Stein GS; Lian JB
Exp Cell Res; 1995 Jan; 216(1):35-45. PubMed ID: 7813631
[TBL] [Abstract][Full Text] [Related]
4. Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.
Atkins GJ; Rowe PS; Lim HP; Welldon KJ; Ormsby R; Wijenayaka AR; Zelenchuk L; Evdokiou A; Findlay DM
J Bone Miner Res; 2011 Jul; 26(7):1425-36. PubMed ID: 21312267
[TBL] [Abstract][Full Text] [Related]
5. Osteonectin regulates the extracellular matrix mineralization of osteoblasts through P38 signaling pathway.
Zhu YS; Gu Y; Jiang C; Chen L
J Cell Physiol; 2020 Mar; 235(3):2220-2231. PubMed ID: 31489629
[TBL] [Abstract][Full Text] [Related]
6. Both JNK1 and JNK2 Are Indispensable for Sensitized Extracellular Matrix Mineralization in IKKβ-Deficient Osteoblasts.
Hao Q; Liu Z; Lu L; Zhang L; Zuo L
Front Endocrinol (Lausanne); 2020; 11():13. PubMed ID: 32117051
[TBL] [Abstract][Full Text] [Related]
7. Time lapse imaging techniques for comparison of mineralization dynamics in primary murine osteoblasts and the late osteoblast/early osteocyte-like cell line MLO-A5.
Dallas SL; Veno PA; Rosser JL; Barragan-Adjemian C; Rowe DW; Kalajzic I; Bonewald LF
Cells Tissues Organs; 2009; 189(1-4):6-11. PubMed ID: 18728354
[TBL] [Abstract][Full Text] [Related]
8. MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM.
Addison WN; Nakano Y; Loisel T; Crine P; McKee MD
J Bone Miner Res; 2008 Oct; 23(10):1638-49. PubMed ID: 18597632
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of mineralising osteoblasts identifies novel genes related to bone matrix mineralisation.
Saad FA; Hofstaetter JG
Int Orthop; 2011 Mar; 35(3):447-51. PubMed ID: 20556378
[TBL] [Abstract][Full Text] [Related]
10. Evidence of vitamin D and interferon-β cross-talk in human osteoblasts with 1α,25-dihydroxyvitamin D3 being dominant over interferon-β in stimulating mineralization.
Woeckel VJ; Koedam M; van de Peppel J; Chiba H; van der Eerden BC; van Leeuwen JP
J Cell Physiol; 2012 Sep; 227(9):3258-66. PubMed ID: 22105341
[TBL] [Abstract][Full Text] [Related]
11. Matrix mineralization controls gene expression in osteoblastic cells.
Wischmann J; Lenze F; Thiel A; Bookbinder S; Querido W; Schmidt O; Burgkart R; von Eisenhart-Rothe R; Richter GHS; Pleshko N; Mayer-Kuckuk P
Exp Cell Res; 2018 Nov; 372(1):25-34. PubMed ID: 30193837
[TBL] [Abstract][Full Text] [Related]
12. Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfal.
Byers BA; Pavlath GK; Murphy TJ; Karsenty G; García AJ
J Bone Miner Res; 2002 Nov; 17(11):1931-44. PubMed ID: 12412799
[TBL] [Abstract][Full Text] [Related]
13. Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation.
Siggelkow H; Rebenstorff K; Kurre W; Niedhart C; Engel I; Schulz H; Atkinson MJ; Hüfner M
J Cell Biochem; 1999 Oct; 75(1):22-35. PubMed ID: 10462701
[TBL] [Abstract][Full Text] [Related]
14. Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes.
Hirao M; Hashimoto J; Yamasaki N; Ando W; Tsuboi H; Myoui A; Yoshikawa H
J Bone Miner Metab; 2007; 25(5):266-76. PubMed ID: 17704991
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.
Al-Jallad HF; Nakano Y; Chen JL; McMillan E; Lefebvre C; Kaartinen MT
Matrix Biol; 2006 Apr; 25(3):135-48. PubMed ID: 16469487
[TBL] [Abstract][Full Text] [Related]
16. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization.
Brandao-Burch A; Utting JC; Orriss IR; Arnett TR
Calcif Tissue Int; 2005 Sep; 77(3):167-74. PubMed ID: 16075362
[TBL] [Abstract][Full Text] [Related]
17. Biglycan modulates osteoblast differentiation and matrix mineralization.
Parisuthiman D; Mochida Y; Duarte WR; Yamauchi M
J Bone Miner Res; 2005 Oct; 20(10):1878-86. PubMed ID: 16160746
[TBL] [Abstract][Full Text] [Related]
18. Stress chaperone GRP-78 functions in mineralized matrix formation.
Ravindran S; Gao Q; Ramachandran A; Blond S; Predescu SA; George A
J Biol Chem; 2011 Mar; 286(11):8729-39. PubMed ID: 21239500
[TBL] [Abstract][Full Text] [Related]
19. 1α,25-dihydroxyvitamin D3 and rosiglitazone synergistically enhance osteoblast-mediated mineralization.
Woeckel VJ; Bruedigam C; Koedam M; Chiba H; van der Eerden BC; van Leeuwen JP
Gene; 2013 Jan; 512(2):438-43. PubMed ID: 22967709
[TBL] [Abstract][Full Text] [Related]
20. HtrA1 inhibits mineral deposition by osteoblasts: requirement for the protease and PDZ domains.
Hadfield KD; Rock CF; Inkson CA; Dallas SL; Sudre L; Wallis GA; Boot-Handford RP; Canfield AE
J Biol Chem; 2008 Feb; 283(9):5928-38. PubMed ID: 18156628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
